Andrew Sealey becomes chairman of Archangels investment syndicate

Summarised from The Herald's report · Updated 5 Nov, 18:21 · Archive

Andrew Sealey has been appointed chairman of Archangels, the Edinburgh-based investment syndicate that his father helped establish. He succeeds Ian Macleod, who chaired the organisation from 2022. Sealey joined Archangels as an investor 34 years ago and became a board member in 2021. He brings significant experience in private capital, having joined advisory firm Campbell Lutyens in 1990, becoming chief executive in 2003, and remaining in that role until 2024. He is now non-executive chairman of Lazard CL, formed after Lazard acquired Campbell Lutyens earlier this year.

Sealey's appointment comes as Archangels increasingly depends on co-investment to fund Scottish businesses. In 2025, the syndicate helped channel £41.1m into Scottish companies, up 50 per cent from £27.3m in 2024. Of this total, members provided roughly £12.8m while co-investors supplied £28.4m. So far in 2026, of £27.8m invested across nine portfolio companies, members have contributed £11.1m and co-investors £16.7m. The recipients have included University of Edinburgh spin-outs Biocaptiva and Bioliberty.

Read the report

• The numbers that show the challenge facing Archangels' new chairmanAndrew Sealey takes the chair at Archangels as co-investment becomes increasingly important to the Edinburgh syndicate's funding of Scottish businessesThe Herald · 5 Nov, 17:00

In this story: Andrew Sealey · Archangels · Barry Sealey · Ian Macleod · Campbell Lutyens · Edinburgh · Scotland · Lazard CL

This summary was written by AI from the headlines and standfirsts above, and states as fact only what at least two outlets report. How we use AI · Report a problem · Corrections log